Skip to main content

核医学市場は世界的なビジネス予測2030年に急成長しています

 


The global radiopharmaceuticals market is poised to grow at a significant pace, owing to growing demand for non-invasive techniques, availability of effective cancer treatment, and ability to observe the functioning of the organ from outside the body. Furthermore, increasing incidence of cancer & cardiovascular aliments, growing demand for alpha radio immunotherapy-based targeted cancer treatment, mounting call for nuclear imaging techniques, and advancements in radiotracers are expected to open new avenues in the radiopharmaceuticals market. Factors that are expected to drive the use of radiopharmaceuticals include changing lifestyle, elevated levels of stress, and ability to identify various diseases sooner than other diagnostic tests. However, factors such as supply volatility & logistical challenges, stringent regulatory vigil, and competition from conventional diagnostic procedures are anticipated to impede the market growth.

The global radiopharmaceuticals market is expected to garner $8,207.5 million by 2022.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1131

The oncology segment contributed more than half of the market share in the overall radiopharmaceuticals market in 2015 and is expected to continue the same trend owing to perpetual rise in the number of cancer cases. The SPECT modality segment dominated the radiopharmaceuticals market in 2015, whereas the PET modality segment is anticipated to grow at a comparatively higher CAGR of 8.3% from 2016 to 2022. PET segment is driven by better quality of image and higher precision in diagnosis. Other reasons attributed to its sustained dominance are growing R&D activities especially in developing economies and widening scope of radiopharmaceutical applications such as thyroid, oncology, and bone pain palliation.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1131

The Asia-Pacific radiopharmaceuticals market is expected to offer lucrative growth opportunities during the forecast period owing to aging population and increasing cancer incidences. The leading Asia-Pacific countries, such as China, Japan, and Australia would exhibit a steady growth rate.

The Major Key Players Are:

·        Mallinckrodt plc.

·        General Electric

·        Medtronic Inc.

·        Bayer AG

·        Cardinal Health Inc.

·        Lantheus Medical Imaging, Inc.

·        IBA Group

·        Bracco Imaging S.p.A.

·        NTP Radioisotopes SOC Ltd.

Key findings of Radiopharmaceuticals Market:

  • Therapeutics segment is projected to be the fastest growing segment in the radiopharmaceuticals market, registering a CAGR of 16.9% from 2016 to 2022.
  • SPECT modality segment is expected to dominate the radiopharmaceuticals market in 2015 and expected to retain its position throughout the study period.
  • Thyroid application segment is expected to exhibit double-digit CAGR of 11%.
  • Oncology application segment is expected to continue to lead the radiopharmaceuticals market, accounting for close to 60% share by 2022.
  • Asia-Pacific is projected to be the fastest growing radiopharmaceuticals market, registering a CAGR of 8.4%.

Access Full Report @ https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Labels:

Comments

Post a Comment

Popular posts from this blog

電子健康記録（EHR）市場 ガーナーへ $33.29 Bn, グローバルに, で 5.0% CAGR

T he global   Electronic Health Records (EHR) Market   generated $24.90 billion in 2017, and is expected to generate $33.29 billion by 2023, registering a CAGR of 5.0% from 2017 to 2023. The report offers a detailed analysis of drivers & opportunities, market size & estimations, top winning strategies, key segments, and competitive scenario. Increase in acceptance of cloud-based EHR software worldwide, surge in incidence of chronic diseases, and rise in ageing population drive the growth of the global EHR market. However, expensive EHR software and rise in concerns regarding data security & safety hinder the growth of the industry. On the other hand, untapped potential in emerging countries create lucrative opportunities in the future. Download Sample Report at:   https://www.alliedmarketresearch.com/request-sample/4542 Based on product, the cloud-based software segment is expected to register the highest CAGR of 5.3% from 2017 to 2023, owing to the less upfront costs and l
Post a Comment
Read more

ライフサイエンス試薬市場、トレンド、分析、機会、シェア、2019-2027年までの予測

  " Life Science Reagents Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report." Life Science Reagents Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the current status of the market, cover market size with respect to valuation as sales volume and providing a precise prediction of the market scenario over the forecast period from 2020 to 2027. Download Free Sample PDF@   https://www.alliedmarketresearch.com/request-sample/12658 The report provides revenue forecast with sales, sales growth rate, and revenue growth rate forecasts of the global    Life S
Post a Comment
Read more

副鼻腔拡張デバイス市場 Expected to Reach $5,778 Million by 2023 - Allied Market Research

  Sinus Dilation Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023 ," the global sinus dilation devices market was valued at   $3,326 million   in 2016, and is projected to reach   $5,778 million   at a CAGR of 8.1% from 2017 to 2023. Sinusitis is a medical condition wherein inflammation of sinus lining leads to a plugged nose, headache, poor sense of smell, sore throat, and cough. It is caused due to either ostial blockage, bacterial infections, viral infections, or a combination of these conditions. This leads to use of sinus dilation devices during surgical procedures to dilate the sinus openings of a patient's nose. Request for Sample Report at:   https://www.alliedmarketresearch.com/request-sample/2128 The major factors that drive the global sinus dilation devices market are increase in incidence of sinusitis, which may lead to higher sinus surgeries, high adoption of minimally invasive surgical procedures, and technologi
Post a Comment
Read more